M&A
Facing a Patent Cliff, GSK Bets on a Potential Best-in-Class Food Allergy Biologic in $2.2B RAPT Deal
2026-01-20
Is Genmab’s New Asset the Next Big Bet in PD-1 Combination Therapy for Head and Neck Cancer?
2025-10-01
AbbVie Buys Bretisilocin from Gilgamesh in $1.2B Deal to Expand Depression Drug Pipeline–Another Win in the Psychedelic Space?
2025-08-27
10x Genomics Invests in the Future with Scale Biosciences Acquisition, Eyes Scalable Growth
2025-08-07
Astellas’ Transformation Journey: From Merger to Global Player, Betting on the Edge of Innovation and Risk?
2025-04-25
The Stargate Project: A $500 Billion Initiative that Will Bring Tech Giants to the AI Table
2025-01-24
LATEST
Forced Migrants in Ukraine Face Barriers to HIV and TB Care Amid Disrupted Healthcare Systems
2026-01-23
Residual Cardiovascular Risk Persists in Coronary Artery Disease Despite Advances in Treatment
2026-01-23
Advocacy-Informed Research and PRISM Framework Highlighted in Healthcare Policy Reform Strategies
2026-01-23
Study Explores Link Between Red Blood Cell Distribution Width and Prognosis in Peripheral T-Cell Lymphoma
2026-01-23



